Liquidia files for IPO

Morrisville-based biopharmaceutical company Liquidia Technologies has filed for an initial public offering. According to Liquidia’s filing, the company plans to raise about $57.5 million in the IPO and list its common stock on the Nasdaq exchange under the ticker LQDA.  The proceeds of the offering are slated to be used for the following, according to the filing: To complete our ongoing Phase 3 cli nical trial of LIQ861;  To advance LIQ865 through our planned Phase 2-enabling toxicology studies…
Source: bizjournals.com Health Care:Biotechnology headlines - Category: Biotechnology Authors: Source Type: news